Debra Kay Liebert

Debra Kay Liebert is a declared insider of Milestone Pharmaceuticals Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 13 May 2019 to 21 October 2022, the count stands at 11 filings.

The open-market record is one-sided, with 7 purchases worth €55k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2022, the count stands at 7 purchases and no sales.

In size, the median ticket on the buying side is €2,333. No cluster: in 7 purchases, no other insider of the company bought within 30 days.

On 21 October 2022 came the latest disclosure, an open-market purchase for €2,333 in Milestone Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.